معرفی
Pamela Hu, MD is an Assistant Professor of Pediatrics in the Section of Diabetes, Endocrinology, and Metabolism at Yale University School of Medicine. She provides comprehensive clinical care for children with endocrine disorders through specialized clinics in general endocrinology, metabolic bone disease, obesity, and type 2 diabetes.
Her educational background includes:
- MD from The George Washington University School of Medicine and Health Sciences (2016)
- Residency in Pediatrics at Yale New Haven Children's Hospital (2019)
- Fellowship in Pediatric Endocrinology at Yale New Haven Children's Hospital
- BA from Wellesley College (2007)
Dr. Hu's research primarily focuses on the management of childhood obesity and its co-morbidities including type 2 diabetes and non-alcoholic fatty liver disease (NAFLD). She is particularly interested in real-world applications of pharmacotherapies like GLP-1 receptor agonists for youth with type 2 diabetes, and has conducted significant research on the impact of the COVID-19 pandemic on children with obesity. Her work also emphasizes quality improvement projects aimed at increasing equitable access to healthcare for pediatric patients with endocrine disorders.
Dr. Hu's publication record demonstrates a strong focus on translational research that bridges clinical practice and scientific investigation in pediatric endocrinology. Her recent work has particularly emphasized the growing epidemic of childhood obesity and type 2 diabetes, with attention to both pharmacological interventions and lifestyle modifications. She frequently collaborates with colleagues including Stephanie Samuels, Michelle Van Name, and Mona Sharifi on studies examining obesity interventions and diabetes management in youth.
Dr. Hu is board-certified in General Pediatrics, Pediatric Endocrinology, and Obesity Medicine, reflecting her comprehensive expertise in caring for children with complex metabolic conditions.
She actively participates in clinical trials in the fields of pediatric metabolic bone disease and both adult and pediatric obesity medicine, contributing to the advancement of evidence-based practices in these areas.
